FDA Inspection 1103039 — Strides Pharma, Inc.
The FDA completed an inspection of Strides Pharma, Inc. on Aug 23, 2019 in Chestnut Ridge, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 23, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chestnut Ridge, NY (United States)
Additional Details
Bioanalytical BA/BE